Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,564,029
+$1,030,866 QoQ
Shares Held
26,085
+2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1,147
of 4,153 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. ABBV ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,564,029 | 26,085 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,533,163 | 25,441 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $6,404,346 | 28,029 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $7,013,346 | 30,290 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $5,811,576 | 31,309 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $6,405,026 | 30,570 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $5,306,832 | 29,864 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $5,944,148 | 30,100 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,212,664 | 30,391 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,500,512 | 30,206 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $4,158,155 | 26,832 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $4,460,620 | 29,925 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,125,197 | 23,196 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $933,748 | 5,859 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $574,361 | 3,554 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $473,224 | 3,526 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $535,294 | 3,495 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $595,430 | 3,673 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $334,573 | 2,471 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $311,420 | 2,887 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $357,632 | 3,175 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $202,154 | 1,868 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||